SWOG clinical trial number
SWOG-8806
A Phase II Study of Recombinant Tumor Necrosis Factor (rTNF) in Patients with Advanced Bladder Cancer (for patients not eligible for SWOG-8594)
Closed
Phase
Accrual
25%
Abbreviated Title
A Phase II Study of Recombinant Tumor Necrosis Factor (rTNF) in Patients with Advanced Bladder Cancer (for patients not eligible for SWOG-8594)
Activated
08/15/1988
Closed
11/15/1990